Xarelto Attorneys for Bleeding Injury Lawsuits
Released in 2011 by Johnson & Johnson in partnership with Bayer, Xarelto (rivaroxaban) thins the blood to prevent blood clots, lowering the risk of stroke for patients who suffer from atrial fibrillation. It is also approved to treat deep vein thrombosis and pulmonary embolism, and is sometimes prescribed following hip or knee replacement.
While the anti-coagulant action of Xarelto can treat these conditions, it can also lead to potentially fatal uncontrollable bleeding.
People harmed by Xarelto must take legal action against the makers of the drug to seek compensation for their suffering.
The pharmaceutical drug injury attorneys at the Monsour Law Firm are ready to help.